FTI Form 4: CFO Exercises Options and Sells Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
TechnipFMC plc (FTI) insider activity: Melin Alf, EVP & Chief Financial Officer, reported multiple transactions on 09/22/2025 executed pursuant to a Rule 10b5-1 trading plan adopted June 23, 2025. The filing shows the exercise/settlement of two employee stock options (6,584 shares at $25.24 and 7,176 shares at $21.10) and the sale of 113,760 ordinary shares in multiple transactions at weighted-average prices of $38.61–$38.62 (with per-trade ranges disclosed). Following these transactions, the reporting person beneficially owned 241,140 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Positive
- Transactions executed under a documented Rule 10b5-1 plan, adopted June 23, 2025, which provides an affirmative defense for planned trades.
- Exercise of employee stock options (6,584 shares at $25.24 and 7,176 shares at $21.10), converting derivative awards into ordinary shares before or concurrent with sales.
- Detailed price ranges and weighted-average prices disclosed in footnotes, offering transparency about the multiple sale executions.
Negative
- Significant insider sales on 09/22/2025 totaling 113,760 shares (100,000 + 6,584 + 7,176), which reduced the reporting person’s post-transaction holdings to 241,140 shares.
- Weighted-average sale prices in the high $30s indicate material proceeds but also represent substantial disposition of shares by the CFO on a single day.
Insights
TL;DR: Routine option exercises and planned selling under a 10b5-1 plan; transactions do not by themselves indicate a change in company fundamentals.
The filings show exercise of vested employee stock options and concurrent market sales executed under a pre-established Rule 10b5-1 plan adopted on June 23, 2025. Total shares sold on 09/22/2025 were 113,760 at weighted-average prices in the high $30s, while option exercises increased share count before sales. This pattern—exercise followed by sales under a trading plan—is common for executives monetizing compensation and is informational rather than conclusive about firm outlook.
TL;DR: Disclosure aligns with typical insider-plan practice; documentation of plan and price ranges adds compliance clarity.
The Form 4 discloses that transactions were effected pursuant to a documented 10b5-1 plan and provides weighted-average sale prices and ranges. The filing also notes anti-dilution adjustments tied to a prior spin-off. The use of an attorney-in-fact signature is permitted and the explanatory footnotes supply required detail for transparency, supporting good disclosure practice.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 6,584 | $0.00 | -- |
| Exercise | Employee Stock Option (right to buy) | 7,176 | $0.00 | -- |
| Exercise | Ordinary Shares | 6,584 | $25.24 | $166K |
| Exercise | Ordinary Shares | 7,176 | $21.10 | $151K |
| Sale | Ordinary Shares | 100,000 | $38.61 | $3.86M |
| Sale | Ordinary Shares | 6,584 | $38.62 | $254K |
| Sale | Ordinary Shares | 7,176 | $38.62 | $277K |
Footnotes (1)
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 23, 2025. This price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.08 to $38.87 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. This price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.62 to $38.87 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. This price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.11 to $38.87 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Reflects the automatic adjustment of the exercise price and number of shares subject to the employee stock option pursuant to anti-dilution provisions contained in the applicable award, which provisions were triggered as a result of the completion of the Issuer's pro-rata distribution of a portion of the outstanding shares of Technip Energies N.V. to the Issuer's shareholders (the "Spin-off") on February 16, 2021.
